Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The LEADLESS II IDE Study (Phase I): Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker

NCT02030418 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT02030418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02030418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The LEADLESS II IDE Study (Phase I): Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
July 15, 2022
Enrollment
952 (actual)
Sites
59

Conditions

As the registry lists them; a condition with its own page is linked.

bradycardia